FDA Approved: POTASSIUM CITRATE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved Rising Pharma Holdings, Inc.'s original ANDA for Potassium citrate, authorizing a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrolithiasis

Drugs mentioned

• POTASSIUM CITRATE (Potassium citrate)

Snippet

ORIG AP for POTASSIUM CITRATE (POTASSIUM CITRATE)